Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Pharmacoepidemiology and Drug Safety|September 24, 2004
Identification of patients with Churg-Strauss syndrome (CSS) using automated dataLeslie R Harrold, Susan E Andrade, Mark Eisner, et al.
The American Journal of Medicine|March 5, 2005
The incidence of adverse drug events in two large academic long-term care facilitiesJerry H Gurwitz, Terry S Field, James Judge, et al.
Arthritis Care & Research|May 26, 2017
Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid ArthritisLeslie R Harrold, George W Reed, Ani John, et al.
BMJ Open|September 4, 2023
Understanding Heterogeneity in Patients' Conceptualisation of Treatment for Rheumatoid Arthritis: A Cluster AnalysisBetty Hsiao, Julie S Downs, Mandy Lanyon, et al.
Arthritis Research & Therapy|April 28, 2016
Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendationsLeslie R Harrold, George W Reed, Joel M Kremer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 18, 2017
Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled TrialDaniel H Solomon, Elena Losina, Bing Lu, et al.
Journal of the American Geriatrics Society|July 24, 2004
Risk factors for adverse drug events among older adults in the ambulatory settingTerry S Field, Jerry H Gurwitz, Leslie R Harrold, et al.
The Journal of Rheumatology|June 9, 2005
Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspectiveLeslie R Harrold, Susan E Andrade, Alan S Go, et al.
Pharmacoepidemiology and Drug Safety|December 29, 2006
Asthma drug use and the development of Churg-Strauss syndrome (CSS)Leslie R Harrold, M Kay Patterson, Susan E Andrade, et al.
Journal of the American Geriatrics Society|December 20, 2008
Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care settingJerry H Gurwitz, Terry S Field, Paula Rochon, et al.
Pageof 13